New Zealand research and cultivation company Greenlab’s Australian subsidiary has entered into an agreement to supply pharmaceutical-grade cannabinoids to Australian distributor Cannvalate.
Under the two-year agreement, Greenlab Australia will supply a range of certified cannabis products that meet Therapeutic Goods Administration (TGA) standards and internationally recognized GMP requirements.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.